Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-20-000113
Filing Date
2020-11-12
Accepted
2020-11-12 08:03:10
Documents
55
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q flks-20200930.htm   iXBRL 10-Q 895934
2 EX-31.1 slrx20200930ex-311.htm EX-31.1 9063
3 EX-31.2 slrx20200930ex-312.htm EX-31.2 8841
4 EX-32.1 slrx20200930ex-321.htm EX-32.1 6511
  Complete submission text file 0001615219-20-000113.txt   4245888

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20200930.xsd EX-101.SCH 27902
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20200930_cal.xml EX-101.CAL 55783
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20200930_def.xml EX-101.DEF 165795
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20200930_lab.xml EX-101.LAB 424586
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20200930_pre.xml EX-101.PRE 269446
10 EXTRACTED XBRL INSTANCE DOCUMENT flks-20200930_htm.xml XML 556730
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 201303476
SIC: 2834 Pharmaceutical Preparations